-
Michael Burd posted an update in the group
Research and Development 2 months, 1 week ago Nintedanib and Perfenidone COMBINED therapy.
As these two drugs attack IPF in different ways there is consensus that taking both will produce better results than monotherapy. I would love to hear from anyone who has any recent testing information.
